BCAL Diagnostics is a biotechnology company that focuses on the detection of women’s health issues.
BCAL Diagnostics has raised $10.5M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2024.
BCAL Diagnostics's investors include Ellerston Capital, APS Foundation, Mark McConnell.
BCAL Diagnostics is headquartered in Sydney, Australia.
BCAL Diagnostics is a biotechnology company that focuses on the detection of women’s health issues.
BCAL Diagnostics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"BCAL Diagnostics — Funding & Investors." VCBacked, June 3, 2024, https://www.vcbacked.co/company/bcal-diagnostics. Accessed August 14, 2026.
VCBacked. (2024). BCAL Diagnostics — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/bcal-diagnostics
{{cite web |title=BCAL Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/bcal-diagnostics |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated